Status:
UNKNOWN
Kardia - A Smartphone-based Care Model for Outpatient Cardiac Rehabilitation
Lead Sponsor:
Changi General Hospital
Collaborating Sponsors:
Biofourmis Inc.
Conditions:
Post MI
Eligibility:
All Genders
21-85 years
Phase:
NA
Brief Summary
This study hopes to target the remaining 80% of low risk post-myocardial infarction patients who have refused uptake the traditional cardiac rehabilitation program In Changi General Hospital. This is ...
Detailed Description
Cardiovascular disease (CVD) is the most common cause of death in Singapore, accounting for \~34% of deaths. This means 1 in every 3 deaths in Singapore is due to heart disease or stroke. Ischemic hea...
Eligibility Criteria
Inclusion
- Age 21-85 years
- Willing and able to provide informed consent
- New onset of Post ST elevation and non-ST elevation myocardial infarction/staged PCI/acute coronary syndrome/unstable angina
- Own and able to operate App on smartphone
Exclusion
- History of ventricular fibrillation not in the setting of acute myocardial infarction
- Documented sustained ventricular or supraventricular arrhythmia
- Unstable angina
- Awaiting staged revascularization
- Inability to perform 6MWT
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03415841
Start Date
February 1 2018
End Date
March 31 2020
Last Update
May 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changi General Hospital
Singapore, Singapore, 529889